The U.S. Food and Drug Administration (FDA) has issued warning for the insomnia drug Lunesta (eszopiclone) based on evidence of next-day impairment of…
A commonly prescribed antidepressant can reduce production of the main ingredient in Alzheimer's brain plaques, according to new research at…
